Actuated Medical

Actuated Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.7M

Overview

Actuated Medical is a pioneering medical device company developing a platform technology centered on engineered motion to improve neurological interventions. Its flagship NeuralGlider system uses micro-oscillations to insert brain implants and deliver biologics with greater precision and less tissue trauma, aiming to improve implant performance and therapeutic outcomes. Founded in 2008, the company is ISO 13485 certified, holds a significant intellectual property portfolio, and collaborates with leading academic and clinical partners. It operates as a preclinical-stage, revenue-generating entity, providing tools and expertise to researchers and therapy developers in the rapidly advancing field of brain health.

Neurological DisordersBrain CancerAddiction

Technology Platform

Patented platform using controlled micro-oscillations (engineered motion) to improve precision and reduce tissue trauma during brain implant insertion and targeted biologics delivery. Commercialized as the NeuralGlider system.

Funding History

2
Total raised:$1.7M
Grant$1.2M
Grant$500K

Opportunities

The company is positioned at the convergence of two massive growth sectors: neuromodulation/brain-computer interfaces and targeted CNS drug delivery.
Its platform-agnostic technology allows it to benefit from the success of multiple therapy developers, offering a scalable model with a large total addressable market.
Strategic partnerships with leading neural interface or pharmaceutical companies could provide rapid validation and commercial scaling.

Risk Factors

Key risks include the need for broader clinical validation to drive surgeon adoption, dependency on the success and timelines of partner companies' therapeutic programs, and potential competition from larger medtech firms developing alternative access technologies.
Technological obsolescence from breakthroughs in non-invasive therapies is a long-term risk.

Competitive Landscape

Actuated Medical operates in the niche of precision brain access tools. Direct competitors may include other specialized research tool companies and in-house R&D teams at large neuromodulation companies (e.g., Medtronic, Boston Scientific, Abbott). Its competitive advantage lies in its patented, focused actuation technology, strong IP portfolio, and early-mover evidence generation in reducing tissue trauma during implantation.